Oncology Institute (TOI) Gross Profit (2021 - 2025)
Oncology Institute's Gross Profit history spans 5 years, with the latest figure at $89.3 million for Q4 2025.
- For Q4 2025, Gross Profit rose 1542.19% year-over-year to $89.3 million; the TTM value through Dec 2025 reached $315.0 million, up 27.94%, while the annual FY2025 figure was $297.2 million, 22.73% up from the prior year.
- Gross Profit reached $89.3 million in Q4 2025 per TOI's latest filing, down from $99.7 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $123.7 million in Q4 2021 to a low of -$6.2 million in Q4 2024.
- Average Gross Profit over 5 years is $56.7 million, with a median of $54.6 million recorded in 2022.
- Peak YoY movement for Gross Profit: tumbled 116.54% in 2024, then soared 1542.19% in 2025.
- A 5-year view of Gross Profit shows it stood at $123.7 million in 2021, then plummeted by 56.24% to $54.1 million in 2022, then tumbled by 30.86% to $37.4 million in 2023, then tumbled by 116.54% to -$6.2 million in 2024, then skyrocketed by 1542.19% to $89.3 million in 2025.
- Per Business Quant, the three most recent readings for TOI's Gross Profit are $89.3 million (Q4 2025), $99.7 million (Q3 2025), and $68.7 million (Q2 2025).